Results 151 to 160 of about 182,660 (317)

Successful Transcatheter Valve-in-Valve Implantation in a Small Deteriorated Aortic Valve Bioprosthesis [PDF]

, 2013
Increased life expectancy and improvement in clinical outcome following surgery has led to an increasing number of elderly patients with a history of prior aortic valve replacement (AVR).
Bjursten, Henrik,, Harnek, Jan,, Nozohoor, Shahab,, Götberg, Matthias,, Lund University.   +4 more
core  

Valve-in-Valve Transcatheter Aortic Valve Replacement for Bioprosthetic Aortic Valve Disease in Pregnancy

JACC: Case Reports
Management of valvular disease in pregnancy is complex. Hemodynamic changes associated with pregnancy may exacerbate underlying disease.A 32-year-old woman with a history of remote bioprosthetic aortic valve replacement (AVR) presented to care in early pregnancy with progressive dyspnea on exertion.
Driggin, Elissa, Bloom, Jason, Kodali, Susheel, Purisch, Stephanie E., Haythe, Jennifer   +4 more
openaire   +2 more sources

Left ventricular diastolic dysfunction worsens prognosis in patients with heart failure due to dilated cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 1183-1193, April 2025.
Abstract Aims The prognostic significance of left ventricular (LV) diastolic dysfunction (LVDD) severity in patients with dilated cardiomyopathy (DCM) remains uncertain. This study aimed to evaluate the association of LVDD severity and elevated left atrial pressure (eLAP) with patient outcomes in stable, non‐acutely decompensated patients with DCM ...
Mateusz Winiarczyk, Ewa Dziewięcka, Sylwia Wiśniowska‐Śmiałek, Agnieszka Stępień, Katarzyna Graczyk, Agata Leśniak‐Sobelga, Marta Hlawaty, Jakub Woźniak, Maryia Savitskaya, Katarzyna Holcman, Magdalena Kostkiewicz, Piotr Podolec, Paweł Rubiś   +12 more
wiley   +1 more source

Aortic allografts in treatment of aortic valve and ascending aorta prosthetic endocarditis [PDF]

, 2017
The aim – to assess short- and long-term results of aortic root replacement using aortic allografts in patients with prosthetic endocarditis. Materials and methods.
S.V. Spiridonov
core  

Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial

ESC Heart Failure, Volume 12, Issue 2, Page 1455-1463, April 2025.
Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli, François Roubille, Nicolas Meyer, Giulio Pompilio, Lionel Leroux, Philippe Henon, Guillaume Trebuchet, Anthony Criquet, Matthieu de Kalbermatten, Eric Saloux, Alain Manrique, Pierre‐Yves Marie, Deepak L. Bhatt, Scott D. Solomon, Gilles Montalescot, David E. Newby, Faiez Zannad, on behalf of the EXCELLENT Trial Investigators   +17 more
wiley   +1 more source

Disruption of Notch1 and Gata5 in Mice Leads to Congenital Aortic Valve Disease

JACC: Basic to Translational Science
Summary: Here, we describe Notch1;Gata5 compound mutant mice as a novel mouse model of highly penetrant congenital aortic valve disease displaying bicuspid aortic valve and progressive aortic valve stenosis.
Jun Yasuhara, MD, PhD, Mona Aljuhani, PhD, Talita Z. Choudhury, PhD, Anupama Rao, PhD, Sara Conroy, PhD, Yukie Ueyama, DVM, Stephanie LaHaye, PhD, Karlee Schultz, MS, Emily M. Cameron, MS, Sathiya N. Manivannan, PhD, Uddalak Majumdar, PhD, Vidu Garg, MD   +11 more
doaj   +1 more source

Real‐world characteristics and treatment of cardiac transthyretin amyloidosis: A multicentre, observational study

ESC Heart Failure, Volume 12, Issue 2, Page 1203-1216, April 2025.
The 366 patients diagnosed with transthyretin amyloidosis cardiomyopathy (ATTR‐CM) were analyzed regarding their clinical characteristics in the first year after approval of tafamidis 61 mg for ATTR‐CM in Germany. Nearly two‐thirds of the patients were in an advanced disease stage and 64% met the key criteria of the “Transthyretin Amyloidosis ...
Richard J. Nies, Svenja Ney, Ingrid Kindermann, Yvonne Bewarder, Angela Zimmer, Fabian Knebel, Katrin Hahn, Sebastian Spethmann, Peter Luedike, Lars Michel, Tienush Rassaf, Maria Papathanasiou, Stefan Störk, Vladimir Cejka, Amin Polzin, Fabian Voss, Malte Kelm, Bernhard Unsöld, Christine Meindl, Michael Paulus, Ali Yilmaz, Bishwas Chamling, Caroline Morbach, Roman Pfister   +23 more
wiley   +1 more source

Transcatheter aortic valve implantation (TAVI): current indications and future scenarios [PDF]

, 2018
Th e introduction of transcatheter aortic valve implantation (TAVI) has represented a major breakthrough in the management of patients with symptomatic severe aortic valve stenosis.
Antonio Giulio Bruno, Tullio Palmerini
core  

Comparative performance of risk prediction indices for mortality or readmission following heart failure hospitalization

ESC Heart Failure, Volume 12, Issue 2, Page 1227-1236, April 2025.
Comparative performance of 7 risk prediction indices in patients hospitalized for heart failure. In this cohort of 1206 patients, the LENT index offered the greatest discrimination, calibration, and overall accuracy in predicting 30‐day composite all‐cause mortality or readmission following hospitalization for heart failure.
Tauben Averbuch, Ali Zafari, Shofiqul Islam, Shun Fu Lee, Rajiv Sankaranarayanan, Stephen J Greene, Mamas A Mamas, Ambarish Pandey, Harriette GC Van Spall   +8 more
wiley   +1 more source

Aortic valve repair [PDF]

Indian Journal of Thoracic and Cardiovascular Surgery, 2019
Om Prakash, Yadava, Hans-Joachim, Schafers   +1 more
openaire   +2 more sources